Fundamental Analysis:
Ticker
HBP:CA
Current Price
$1.52 -4.4%
Market Cap
$112.7M
Price Target
Refer to Report
Volume
1.3K
52wk Range
$0.5 - $1.6
Overview
Helix BioPharma Corp is a Canada-based clinical-stage biopharmaceutical company focused on cancer drug development. It develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. The company has Tumor Defense Breakers (L-DOS47), and Tumor Attackers (CAR-T) product candidates in the pipeline.